// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

What Matters the Most for Parents, Patients and Clinicians in Predicting the Course of Juvenile Idiopathic Arthritis (JIA)?

Susanne Benseler - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Assessment of Musculoskeletal Abnormalities in Children with Mucopolysaccharidoses Using a Simple Musculoskeletal Examination (Paediatric Gait, Arms, Legs and Spine)

Ethan Sen - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Contentious Points in the Formulation of Evidence-Based Guidelines for the Management of Fibromyalgia in Canada

Peter Ste-Marie - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Fibromyalgia

N/A

An Innovative Strategy to Implement Clinical Practice Guidelines for People Living with Rheumatoid Arthritis and Osteoarthritis through Facebook

Gino De Angelis - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Rheumatoid arthritis

N/A

A Retrospective Study to Evaluate the Safety, Efficacy, and Drug Survival of Rituximab in Rheumatoid Arthritis Patients in a Single Canadian Practice

Alpesh Shah - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Rituximab

Self Reported Comorbidity is Common in Early Inflammatory Arthritis and Associated with Poorer Function and Quality of Life and Greater Disease Activity: Results from the Canadian Early Arthritis Cohort

Gilles Boire - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Early inflammatory arthritis

N/A

A Retrospective Study to Evaluate the Effectiveness, Safety and Drug Survival of Tocilizumab in Rheumatoid Arthritis Patients in a Single Hamilton Practice

Matthew Got - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Tocilizumab

Needs Assessment for the Development of a New Online Accredited Educational Program on Rheumatoid Arthritis and Osteoarthritis.

Mary Bell - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Rheumatoid arthritis

N/A

TEAM-Managed Care of Biological Patients at a Canadian Centre

Dawn Heap - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Treatment of Asymptomatic Hyperuricemia for the Prevention of Gouty Arthritis, Renal Disease and Cardiovascular Events: Systematic Review

Mihir Wechalekar - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Coronary Artery Disease

N/A

Efficacy of Denosumab after Implementation of Charlton Patient Advocacy Program

Arthur Lau - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Denosumab

Myopathy is a Poor Prognostic Feature in Systemic Sclerosis. Results from the Canadian Scleroderma Research Group (CSRG) Cohort

Marie Hudson - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Scleroderma

N/A

The Use of the International Classification of Function, Disability and Health as a Conceptual Framework for Comparison of the Content of Core Outcome Instruments with the Patient Perspective in Vasculitis

Peter Merkel - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

All Cause Hospitalizations in Systemic Lupus Erythematosus from a Large Referral Center Demonstrate More Intensive Care and Longer Length of Stay

June Lee - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Correlation of Monosodium Urate Gouty Tophi with Colour Coded Dual Energy Computed Tomography Images

Savvas Nicolaou - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Gout/hyperuricemia

Everolimus

The Role of Phospholipids Profile in Disease Activity and Surrogate Markers of Cardiovascular Disease in Systemic Lupus Erythematosus

David Ma - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Kimuras Disease and Steroid-Sparing Immunosuppressive Therapy

Roaa Alsolaimani - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Addition of a Nurse to Outpatient Rheumatologic Practice Can Enhance Patient Care and Potentially Increase Adherence to Treatment, while Decreasing Burden on Family Physician Services

Jason Kur - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Development and Validation of Definitions for Digital Ulcers in Systemic Sclerosis

Lorinda Chung - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Limitations of Estimated FRAX 10-Year Fracture Risk at the Time of Incident Fracture and Upon Refracture: Results from the OPTIMUS Initiative

Pierre-Marc April - Canadian Rheumatology Association (CRA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

N/A

Copyright © 2026. QuantiNova All rights reserved